<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2025-03-31</publicationDate>
    
        <volume>18</volume>
        <issue>1</issue>

 
    <startPage>527</startPage>
    <endPage>534</endPage>

	 
      <doi>10.13005/bpj/3105</doi>
        <publisherRecordId>64037</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Nutritional Management of Polycystic Ovary Syndrome (PCOS)- A Review</title>

    <authors>
	 


      <author>
       <name>Apoorva Jain</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Asha Neravi</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Sunil Kumar Katti Sathyasheelappa</name>

		
	<affiliationId>2</affiliationId>
      </author>
    

	 


      <author>
       <name>Ajay Kumar Oli</name>

		
	<affiliationId>1</affiliationId>
      </author>
    


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Biomedical Science, SDM Research Institute for Biomedical Sciences, Shri Dharmasthala Manjunatheshwara University, Sattur, Dharwad, Karnataka, India</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Obstetrics and Gynaecology, SDM College of Medical Sciences and Hospital, Shri Dharmasthala Manjunatheshwara University, Sattur, Dharwad, Karnataka, India</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">Polycystic ovary syndrome (PCOS) is an endocrine condition affecting women of reproductive age. The prevalence of PCOS is about 4-20% of women globally, leading to reproductive, hormonal, and metabolic abnormalities. PCOS result in Insulin resistance, raises the chronic metabolic risk such as hypertension, dyslipidaemia, cardiovascular disorders, type 2 diabetes and endometrial and/or breast cancer. The exact pathophysiology of PCOS is unknown, but it is evident from the study that lifestyle modifications and tailored diet therapy are the important therapeutic strategies in women. The diet treatment must be able to improve metabolic, reproductive, and insulin resistance functions, which can be reached through the design of a diet with low-calorie  for loss of weight  or maintain a balanced body mass index, limiting the intake of simple sugars and high-caloric food, restricting the intake of food with a low glycaemic index, reducing the consumption of saturated and trans fatty acids, consuming prebiotic food, and focusing on potential deficiency of  vitamin D and omega-3 fatty acid. The purpose of this study is to present a critical literature analysis on dietary management as a novel therapy strategy for the PCOS.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol18no1/nutritional-management-of-polycystic-ovary-syndrome-pcos-a-review/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Glycaemic index</keyword>
      

      
        <keyword> Insulin resistance</keyword>
      

      
        <keyword> Nutritional management</keyword>
      

      
        <keyword> Polycystic ovary syndrome</keyword>
      

      
        <keyword> Pathophysiology</keyword>
      

      
        <keyword> Vitamin D</keyword>
      
</keywords>
  </record>
</records>